What is Hoppr?
Hoppr operates at the intersection of artificial intelligence and medical imaging, offering a comprehensive infrastructure platform designed specifically for developers and PACS vendors. The company addresses the complex challenges of AI model development by providing access to curated, high-quality data with verified provenance. This focus on data integrity and quality management systems is essential for navigating the stringent regulatory requirements associated with medical software. By streamlining the path to marketing authorization, Hoppr enables its partners to accelerate the delivery of AI-driven diagnostic tools, ultimately aiming to enhance patient outcomes and optimize clinical workflows on a global scale.
How much funding has Hoppr raised?
Hoppr has raised a total of $31.5M across 1 funding round:
Series A
$31.5M
Series A (2025): $31.5M with participation from Greycroft Partners, Morningside Capital, Health2047, Kivu Ventures, PSG Equity, and Fortitude Ventures
Key Investors in Hoppr
Greycroft Partners
A leading venture capital firm focused on the Internet and mobile markets, leveraging an extensive network to help entrepreneurs build successful, scalable businesses.
Morningside Capital
A private equity firm specializing in secondary and portfolio financing, providing innovative liquidity solutions and capital support to help partnerships meet their strategic needs.
Health2047
A venture studio powered by the American Medical Association that focuses on founding and scaling companies to transform healthcare diagnostics and care delivery.
What's next for Hoppr?
With this latest injection of capital, Hoppr is well-positioned to scale its operations and deepen its integration within the healthcare ecosystem. The company's strategic roadmap likely involves expanding its library of foundation models and enhancing its quality management frameworks to support broader regulatory compliance across international markets. As the industry shifts toward more sophisticated, multi-modal AI applications, Hoppr's infrastructure will be pivotal in ensuring that these technologies are not only innovative but also reliable and ready for widespread clinical adoption. The firm's focus on developer-centric tooling suggests a long-term strategy to become the standard operating environment for medical AI development.
See full Hoppr company page
